ANI Pharmaceuticals, Inc.

ANIP Healthcare
$81.1 $-0.41 (-0.50%)
Market Cap: $1.7 B
Gurus Holding
6
Popularity Rank
#1196
% of Shares Held
3.74%
Net Activity (Q3 2025)
+$50.18 M

Guru Ownership Trend

Guru Analysis for ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals, Inc. (ANIP), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $63.37 M.

Top institutional holders include Steven Cohen and Renaissance Technologies.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $50.18 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies who increased their stake by 112.6%. Conversely, Cliff Asness reduced exposure by 22.2%.

Portfolio Manager % Portfolio Activity Shares Value Period
0.06% New Buy 399,092 $36.56 M Q3 2025
0.03% Add 112.6% 272,902 $25 M Q3 2025
0.02% Reduce -14.0% 74,460 $6.82 M Q3 2025
0.00% Reduce -22.2% 14,480 $1.33 M Q3 2025
0.00% New Buy 11,850 $1.09 M Q3 2025
0.00% New Buy 8,588 $786,661 Q3 2025

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2025)

+$51.67 M
Total Buy Value
New Buys 3
Additions 1
-$1.49 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
2
Net Buyers
4

FAQs for ANI Pharmaceuticals, Inc. (ANIP)

Top Guru holders include Steven Cohen ($36.56 M), Renaissance Technologies ($25 M), HOTCHKIS & WILEY ($6.82 M). Collectively, tracked Gurus hold 781,372 shares.

Based on recent 13F filings, the sentiment is Positive (Net Buy). There was a net inflow of $50.18 M, with 4 Gurus buying and 2 Gurus selling.

In the recent quarter, 2 Gurus reduced their positions, and 0 Gurus sold out of ANIP completely. Total sell value was $1.49 M.

Yes, 3 Gurus opened new positions in ANIP, and 1 added to their existing holdings. Total buy value was $51.67 M.